REQUEST A DEMO
Total
USD $0.00
Search more companies

Boryung Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Boryung Corporation Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Boryung Corporation is a company in the domestic pharmaceutical industry. The company focuses on pharmaceuticals and space-related businesses, particularly in the production of essential cancer drugs. Boryung has also ventured into space investments through a joint venture with Axiom Space called BRAX Space. The company aims to expand its business globally and acquire original essential cancer drugs, as well as invest in the development of vital medicines for patients.

Headquarters
66-21 Boryung Building, Wonnahm-Dong, Jongno-Gu
Seoul; Seoul; Postal Code: 110-750

Contact Details: Purchase the Boryung Corporation report to view the information.

Website: http://www.boryung.co.kr

Basic Information
Total Employees:
Purchase the Boryung Corporation report to view the information.
Outstanding Shares:
Purchase the Boryung Corporation report to view the information.
Registered Capital:
Purchase the Boryung Corporation report to view the information.
Financial Auditors:
Purchase the Boryung Corporation report to view the information.
Incorporation Date:
November 11, 1963
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
12.16%
Purchase this report to view the information.
1.39%
Company Performance
Financial values in the chart are available after Boryung Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
12.41%
Total operating revenue
12.36%
Operating profit (EBIT)
12.84%
EBITDA
16.9%
Net Profit (Loss) for the Period
-28.32%
Total assets
2.83%
Total equity
5.43%
Operating Profit Margin (ROS)
0.03%
Net Profit Margin
-3.13%
Return on Equity (ROE)
-2.99%
Debt to Equity Ratio
-2.82%
Quick Ratio
-0.44%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?